Integer (ITGR) Proxy filing summary

Executive summary

• Entered into a definitive agreement to be acquired by KKR, marking a significant milestone and strategic transition.

• Transaction aims to provide immediate and certain value to stockholders and leverage KKR’s healthcare expertise for future growth.

• Forward-looking statements highlight anticipated benefits, strategic rationale, and ongoing investment in associates and capabilities.

• Actual results may differ due to various risks, including regulatory approvals, market reactions, and operational disruptions.

Voting matters and shareholder proposals

• Stockholders will be asked to approve the acquisition transaction and related matters via a proxy statement on Schedule 14A.

• Proxy materials will include important information regarding the transaction and participants in the solicitation.

Board of directors and corporate governance

• Directors and executive officers may be deemed participants in the proxy solicitation for the transaction.

• Information about board members, executive officers, and their interests will be disclosed in the proxy statement and related filings.